0001683168-21-004018.txt : 20210831 0001683168-21-004018.hdr.sgml : 20210831 20210831182335 ACCESSION NUMBER: 0001683168-21-004018 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210810 FILED AS OF DATE: 20210831 DATE AS OF CHANGE: 20210831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crabtree Gerald W CENTRAL INDEX KEY: 0001564239 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40699 FILM NUMBER: 211228155 MAIL ADDRESS: STREET 1: 12510 PROSPERITY DR. STREET 2: SUITE #310 CITY: SILVER SPRING STATE: MD ZIP: 20904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc. CENTRAL INDEX KEY: 0001157075 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621772151 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 BUSINESS PHONE: (917) 595.2850 MAIL ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 FORMER COMPANY: FORMER CONFORMED NAME: NUVILEX, INC. DATE OF NAME CHANGE: 20090324 FORMER COMPANY: FORMER CONFORMED NAME: EFOODSAFETY COM INC DATE OF NAME CHANGE: 20010808 3 1 ownership.xml X0206 3 2021-08-10 0 0001157075 PharmaCyte Biotech, Inc. PMCB 0001564239 Crabtree Gerald W 23046 AVENIDA DE LA CARLOTA SUITE 600 LAGUNA HILLS CA 92653 1 1 0 0 Chief Science Officer Common Stock 11200 D Stock Option (right to buy) 156.00 2017-03-09 2022-03-09 Common Stock 1000 D Stock Option (right to buy) 83.70 2018-01-01 2023-01-01 Common Stock 1000 D Stock Option (right to buy) 74.25 2019-03-20 2024-03-20 Common Stock 1000 D Stock Option (right to buy) 61.20 2020-01-02 2025-01-01 Common Stock 1000 D Stock Option (right to buy) 10.05 2021-01-01 2025-12-31 Common Stock 1000 D The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021 (the "Reverse Split"). The exercise price has been adjusted to reflect the Reverse Split. The option vested in twelve equal monthly installments beginning on January 1, 2021. /s/ Gerald W. Crabtree 2021-08-31